missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ CD275 (B7-H2) Polyclonal Antibody
Rabbit Polyclonal Antibody
Brand: Invitrogen™ PA5119204
This item is not returnable.
View return policy
Description
CD275 (B7-H2) Polyclonal Antibody for Western Blot, IHC (P)
Inducible co-stimulator ligand (ICOSL) is a specific ligand on antigen-presenting cells and cells of the peripheral tissue that binds to the inducible co-stimulator receptor (ICOS). ICOS belongs to the CD28/CD152 receptor family that regulates T-cell activation and function. ICOSL is expressed on monocytes, dendritic cells and B cells and can be induced by inflammatory stimuli in peripheral tissue. Binding to ICOSL delivers a co-stimulatory signal for T cell proliferation and cytokine secretion.
Specifications
| CD275 (B7-H2) | |
| Polyclonal | |
| Unconjugated | |
| ICOSLG | |
| AU044799; B7 homolog 2; B7 homologue 2; B7h; B7H2; B7-H2; B7-like protein Gl50; B7-related protein 1; B7RP1; B7RP-1; BG071784; CD275; GI50; GL50; GL50-B; ICOS ligand; ICOSL; ICOS-L; ICOSLG; inducible T-cell costimulator ligand; inducible T-cell co-stimulator ligand; KIAA0653; LICOS; Ly115l; mKIAA0653; RGD1562791; transmembrane protein B7-H2 ICOS ligand | |
| Rabbit | |
| Antigen affinity chromatography, Protein A | |
| RUO | |
| 23308 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Liquid |
| Immunohistochemistry (Paraffin), Western Blot | |
| 0.5 mg/mL | |
| PBS with 50% glycerol and 0.05% ProClin 300; pH 7.4 | |
| O75144 | |
| ICOSLG | |
| Recombinant protein Inducible T-Cell Co Stimulator Ligand. The antigen corresponds to amino acid range Ala1655-Asp1918 of the target protein. | |
| 200 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?